Dowling & Yahnke LLC Geron Corp Transaction History
Dowling & Yahnke LLC
- $215 Million
- Q3 2022
A detailed history of Dowling & Yahnke LLC transactions in Geron Corp stock. As of the latest transaction made, Dowling & Yahnke LLC holds 39,047 shares of GERN stock, worth $142,912. This represents 0.04% of its overall portfolio holdings.
Number of Shares
39,047
Previous 39,047
-0.0%
Holding current value
$142,912
Previous $61,000
49.18%
% of portfolio
0.04%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GERN
# of Institutions
275Shares Held
491MCall Options Held
1.87MPut Options Held
690K-
Black Rock Inc. New York, NY46.6MShares$170 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY44.1MShares$161 Million3.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.4MShares$119 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA32.3MShares$118 Million2.04% of portfolio
-
State Street Corp Boston, MA29MShares$106 Million0.01% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $1.38B
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...